PROSOLV^®

Over 20 years ago, JRS PHARMA developed a new and innovative excipient, PROSOLV® SMCC (silicified microcrystalline cellulose), to alleviate some of the known deficiencies of conventional binders including: low bulk density, poor flow, loss of compatibility, stickiness issues, and sensitivity to lubricants. PROSOLV® SMCC not only addresses these challenges, but also offers enhanced performance.